NYU Investigational Pharmacy — New York, New York

NYU Investigational Pharmacy is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

NYU Investigational Pharmacy has participated in 5 clinical trials.

Therapeutic areas: Renal Cell Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Advanced Solid Tumors.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Investigational Pharmacy?

NYU Investigational Pharmacy has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Investigational Pharmacy conducted?

NYU Investigational Pharmacy has 5 clinical trials on record. Their work covers Renal Cell Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Advanced Solid Tumors.

Is NYU Investigational Pharmacy accredited by Crixeo Health?

NYU Investigational Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Investigational Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.